A single dose of sulthiame induces a selective increase in resting motor threshold in human motor cortex: A transcranial magnetic stimulation study

Epilepsy Research

Volumn 72, Issue 1, 2006, Pages 18-24

  Siniatchkin, Michael ^a   Groppa, Sergey ^a   Siebner, Hartwig ^a   Stephani, Ulrich ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Cortical excitability; Ion channels; Sulthiame; Transcranial magnetic stimulation

Indexed keywords

PLACEBO; SULTIAME;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; BRAIN CELL; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DRUG EFFECT; EVOKED CORTICAL RESPONSE; EVOKED MUSCLE RESPONSE; EXCITABILITY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERVENTILATION; MALE; MOTOR CORTEX; NAUSEA; NERVE EXCITABILITY; NERVE FIBER MEMBRANE STEADY POTENTIAL; NORMAL HUMAN; OUTCOME ASSESSMENT; PARESTHESIA; PRIORITY JOURNAL; RESTLESSNESS; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; ANTICONVULSANTS; CEREBRAL CORTEX; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; THIAZINES; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 33750287243     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2006.07.001     Document Type: Article

References (36)

1. Bast T., Völp A., Wolf C., Rating D., and for the Sulthiame Study Group. The influence of sulthiame of EEG in children with benign childhood epilepsy with centrotemporal spikes (BECTS). Epilepsia 44 (2003) 215-220
2. Boroojerdi B., Battaglia F., Muellbacher W., and Cohen L.G. Mechanisms influencing stimulus-response properties of the human corticospinal system. Clin. Neurophysiol. 112 (2001) 931-937
3. Brockmeier F.K. Effect of sulthiame (Ospolot) in children with refractory epilepsy. Epilepsia 44 Suppl. 8 (2003) 148
4. Chen R., Samii A., Canos M., Wassermann E.M., and Hallett M. Effects of phenytoin on cortical excitability in humans. Neurology 49 (1997) 881-883
5. Debus O.M., and Kurlemann G. Sulthiame in the primary therapy of West syndrome: a randomized double-blind placebo-controlled add-on trial on baseline pyridoxine medication. Epilepsia 45 (2004) 103-108
6. Gross-Selbeck G. Treatment of "binign" partial epilepsies of childhood, including atypical cases. Neuropediatrics 26 (1995) 45-50
7. Iijima T., Ciani S., and Hagiware S. Effects of the external pH on Ca channels: experimental studies and theoretical considerations using a two-site, two-ion model. Proc. Natl. Acad. Sci. USA 83 (1986) 654-658
8. Inghilleri M., Berardelli A., Marchetti P., and Manfredi M. Effect of diazepam, baclofen, and Thiopental on the silent period evoked by transcranial magnetic stimulation in human. Exp. Brain Res. 109 (1996) 467-472
9. Kukumberg P., Benetin J., and Kuchar M. Changes of motor evoked potential amplitudes following magnetic stimulation after hyperventilation. Electromyogr. Clin. Neurophysiol. 36 (1996) 271-273
10. Kujirai T., Caramia M.D., Rothwell J.C., Day B.L., Thompson P.D., Ferbert A., Wroe S., Asselman P., and Marsden C.D. Corticocortical inhibition in human motor cortex. J. Physiol. 471 (1993) 501-519
11. Leniger T., Wiemann M., Bingmann D., Widman G., Hufnagel A., and Bonnet U. Carbonic anhydrase inhibitor sulthiame reduces intracellular pH and epileptiform activity of hippocampal CA3 neurons. Epilepsia 43 (2002) 469-474
12. Madeja M., Wolf C., and Speckmann E.J. Reduction of voltage-operated sodium currents by the anticonvulsant drug sulthiame. Brain Res. 900 (2001) 88-94
13. Maeda F., Gangitano M., Thall M., and Pascual-Leone A. Inter- and intra-individual variability of paired-pulse curves with transcranial magnetic stimulation (TMS). Clin. Neurophysiol. 113 (2002) 376-382
14. Malcolm M.P., Triggs W.J., Light K.E., Shechtman O., and Khandekar G. Reliability of motor cortex transcranial magnetic stimulation in four muscle representations. Clin. Neurophysiol. 117 (2006) 1037-1046
15. Manganotti P., Bongiovanni L.G., Zanette G., Turazzini M., and Fiaschi A. Cortical excitability in patients after loading doses of lamotrigine: a study with magnetic brain stimulation. Epilepsia 40 (1999) 316-321
16. May, T., Boenigk, H.E., Korn-Merker, E., Rambeck, B., 1991. Sulthiam - Einflußfaktoren of Serumkonzentration und tageszeitliche Schwankungen. In: D. Scheffner (Ed.), Epilepsie 91, Magdeburg, pp. 459-466.
17. Mavroudakis N., Caroyer J.M., Brunko E., and Zegers de Beyl D. Effects of diphenylhydantoin on motor potentials evoked with magnetic stimulation. Electroencephalogr. Clin. Neurophysiol. 93 (1994) 428-433
18. Mavroudakis N., Caroyer J.M., Brunko E., and Zegers de Beyl D. Effects of vigabatrin on motor potentials with magnetic stimulation. Electroencephalogr. Clin. Neurophysiol. 105 (1997) 124-127
19. Patsalos P.N., and Lascelles P.T. Changes in regional brain levels of amino acid putative neurotransmitters after prolonged treatment with the anticonvulsant drugs diphenylhydantoin, phenobarbitone, sodium valproate, ethosuximide, and sulthiame in the rat. J. Neurochem. 36 (1981) 688-695
20. Priori A., Berardelli A., Mercuri B., Inghilleri M., and Manfredi M. The effect of hyperventilation on motor cortical inhibition in humans: a study of the electromyographic silent period evoked by transcranial brain stimulation. Electroencephalogr. Clin. Neurophysiol. 97 (1995) 69-72
21. Rating D., Wolf C., Bast T., and for the Sulthiame Study Group. Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: a 6-month randomized, double-blind, placebo-controlled study. Epilepsia 41 (2000) 1284-1288
22. Reis J., Tergau F., Hamer H.M., Müller H.H., Knake S., Fritsch B., Oertel W.H., and Rosenow F. Topiramate selectively decreases intracortical excitability in human motor cortex. Epilepsia 43 (2002) 1149-1156
23. Reis J., Wentrup A., Hamer H.M., Mueller H.H., Knake S., Tergau F., Oertel W.H., and Rosenow F. Levetiracetam influences human motor cortex excitability mainly by modulation of ion channel function-a TMS Study. Epilepsy Res. 62 (2004) 41-51
24. Rossini P.M., Berardelli A., Deutchl G., Hallett M., Maertens de Noordhout A.M., Paulus W., and Pauri F. Applications of magnetic cortical stimulation. The International Federation of Clinical Neurophysiology. Electroencephalogr. Clin. Neurophysiol. Suppl. 52 (1999) 171-185
25. Saad S.F. A possible role of gamma-aminobutyric acid in the mechanism of anticonvulsant action of some carbonic anhydrase inhibitors. IRCS Med. Sci. 4 (1976) 556
26. Schulze-Bonhage A., Knott H., and Ferbert A. Effects of carbamazepine on cortical excitatory and inhibitory phenomena: a study with paired transcranial magnetic stimulation. Electroencephalogr. Clin. Neurophysiol. 99 (1996) 267-273
27. Seyal M., Mull B., and Gage B. Increased excitability of the human corticospinal system with hyperventilation. Electroencephalogr. Clin. Neurophysiol. 109 (1998) 263-267
28. Siebner H.R., Dressnandt J., Auer C., and Conrad B. Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia. Muscle Nerve 21 (1998) 1209-1212
29. Tang C.M., Dichter M., and Morad M. Modulation of the N-methyl-d-aspartate channel by extracellular H. Proc. Natl. Acad. Sci. USA 87 (1990) 6445-6449
30. Tergau F., Wischer S., Somal H.S., Nitsche M.A., Mercer A.J., Paulus W., and Steinhoff B.J. Relationship between lamotrigine oral dose, serum level and ist inhibitory effect on CNS: insights from transcranial magnetic stimulation. Epilepsy Res. 56 (2003) 67-77
31. Traynelis S.F. pH modulation of ligand-gated ion channels. In: Kaila K., and Ransom B.R. (Eds). PH and Brain Function (1998), Wiley-Liss, New York 417-426
32. Wassermann E.M. Variation in the response to transcranial magnetic brain stimulation in the general population. Clin. Neurophysiol. 113 (2002) 1165-1171
33. Werhahn K.J., Kunesch E., Noachtar S., Benecke R., and Classen J. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J. Physiol. (London) 517 (1999) 591-597
34. Ziemann U. TMS and drugs. Clin. Neurophysiol. 115 (2004) 1717-1729
35. Ziemann U., Lönnecker S., Steinhoff B.J., and Paulus W. Effect of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann. Neurol. 40 (1996) 367-378
36. Ziemann U., Lönnecker S., Steinhoff B.J., and Paulus W. The effect of lorazepam on the motor cortex excitability in man. Exp. Brain Res. 109 (1996) 127-135